Radiant Biotherapeutics Inc. — Form D
Radiant Biotherapeutics Inc. of Montreal QC, Z4, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-01. The offering totals $34.3M, of which $34.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-10-01
- Form: D
- Accession: 0002038848-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $34.3M
- Amount sold: $34.3M
- Minimum investment: $500K
- Investors: 7
- Date of first sale: 2024-08-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-525543
Issuer
- Name: Radiant Biotherapeutics Inc.
- CIK: 0002038848
- Entity type: Corporation
- Jurisdiction: QUEBEC, CANADA
- Incorporated: 2020
- Address: 3, Place Ville-Marie, Montreal QC, Z4, H2B 0E7
- Phone: 514-298-4222
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Arthur Fratamico | Executive Officer | Montreal QC, Z4 |
| Arthur Fratamico | Promoter | Montreal QC, Z4 |
More